Analysts expect Intensity Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.08 M | 13.59 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.14 M | 11.51 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.61 M | 12.55 M |
Analysts expect Intensity Therapeutics, Inc. to report earnings per share of -0.95 for Q3 26, against a range of -1.01 to -0.89. The most recent reported quarter, Q2 26, came in at -1.11, a 37.0% miss against the -0.81 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -6.25 | -5.50 | -5.50 | -3.25 | -1.50 | 1.69 | -0.96 | -1.11 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -6.63 | -5.19 | -4.41 | -4.22 | -1.53 | -1.21 | -0.94 | -0.74 | -0.89 | -0.65 | -0.53 | -0.51 | 0.23 | 0.91 | -1.35 | -1.18 | ||||||||||
| Low Estimate | -7.67 | -6.31 | -4.97 | -4.64 | -1.73 | -1.35 | -1.10 | -0.88 | -1.01 | -0.79 | -0.61 | -0.55 | 0.21 | 0.79 | -1.55 | -1.38 | ||||||||||
| Consensus Estimate | -7.15 | -5.75 | -4.69 | -4.43 | -1.63 | -1.28 | -1.02 | -0.81 | -0.95 | -0.72 | -0.57 | -0.53 | 0.22 | 0.85 | -1.45 | -1.28 |
Pull Wall Street consensus for Intensity Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=INTS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "INTS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=INTS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();